Dyslipidaemias Clinical Trial
Official title:
A Study in Healthy Volunteers of Single Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Compound Alone and When Co-administered With Sitagliptin
This study is the first study in humans to assess the safety and tolerability of various doses of GSK1292263 alone, and taken with sitigliptan.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01218204 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
|
Phase 2 | |
| Completed |
NCT00551694 -
A Second Study to Determine the Effect of GSK256073A on HVTs
|
Phase 1 | |
| Completed |
NCT00169559 -
Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
|
Phase 2 | |
| Completed |
NCT00808093 -
Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects
|
Phase 1 | |
| Completed |
NCT00488449 -
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00903617 -
Study to Test GSK256073 in Patients With Dyslipidemia
|
Phase 2 | |
| Completed |
NCT00474864 -
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
|
Phase 2 | |
| Completed |
NCT00608699 -
A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT00318617 -
Effect Of GW501516X On How The Heart Obtains And Uses Energy
|
N/A | |
| Completed |
NCT00388180 -
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation
|
N/A | |
| Completed |
NCT00158899 -
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
|
Phase 2 |